| Impact of COVID-19 on the thyroid gland: an update L Scappaticcio, F Pitoia, K Esposito, A Piccardo, P Trimboli Reviews in endocrine and metabolic disorders, 1-13, 2021 | 279 | 2021 |
| Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials MI Maiorino, S Signoriello, A Maio, P Chiodini, G Bellastella, ... Diabetes Care 43 (5), 1146-1156, 2020 | 222 | 2020 |
| Obesity and hypovitaminosis D: causality or casualty? S Migliaccio, A Di Nisio, C Mele, L Scappaticcio, S Savastano, A Colao, ... International journal of obesity supplements 9 (1), 20-31, 2019 | 143 | 2019 |
| GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs D Giugliano, L Scappaticcio, M Longo, P Caruso, MI Maiorino, ... Cardiovascular Diabetology 20, 1-11, 2021 | 141 | 2021 |
| Metabolic syndrome and cancer:“The common soil hypothesis” G Bellastella, L Scappaticcio, K Esposito, D Giugliano, MI Maiorino Diabetes research and clinical practice 143, 389-397, 2018 | 91 | 2018 |
| Insights into the relationships between diabetes, prediabetes, and cancer L Scappaticcio, MI Maiorino, G Bellastella, D Giugliano, K Esposito Endocrine 56 (2), 231-239, 2017 | 87 | 2017 |
| SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs D Giugliano, M Longo, L Scappaticcio, G Bellastella, MI Maiorino, ... Cardiovascular Diabetology 20, 1-11, 2021 | 81 | 2021 |
| COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review P Trimboli, C Cappelli, L Croce, L Scappaticcio, L Chiovato, M Rotondi Frontiers in endocrinology 12, 707726, 2021 | 75 | 2021 |
| Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma? M Castellana, A Piccardo, C Virili, L Scappaticcio, G Grani, C Durante, ... Cancer cytopathology 128 (4), 250-259, 2020 | 64 | 2020 |
| Mediterranean diet cools down the inflammatory milieu in type 2 diabetes: the MÉDITA randomized controlled trial MI Maiorino, G Bellastella, M Petrizzo, L Scappaticcio, D Giugliano, ... Endocrine 54, 634-641, 2016 | 64 | 2016 |
| Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis L Scappaticcio, M Castellana, C Virili, G Bellastella, M Centanni, ... Journal of endocrinological investigation 43, 219-229, 2020 | 60 | 2020 |
| Glucagon-like peptide-1 receptor agonists and prevention of stroke systematic review of cardiovascular outcome trials with meta-analysis G Bellastella, MI Maiorino, M Longo, L Scappaticcio, P Chiodini, ... Stroke 51 (2), 666-669, 2020 | 52 | 2020 |
| Obesity Programs of nutrition S Migliaccio, A Di Nisio, C Mele, L Scappaticcio, S Savastano, A Colao Education, Research and Assessment (OPERA) Group. Obesity and …, 2019 | 52 | 2019 |
| Erectile dysfunction in young men with type 1 diabetes MI Maiorino, G Bellastella, E Della Volpe, O Casciano, L Scappaticcio, ... International Journal of Impotence Research 29 (1), 17-22, 2017 | 50 | 2017 |
| Diagnostic testing for Graves' or non‐Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography L Scappaticcio, P Trimboli, F Keller, M Imperiali, A Piccardo, L Giovanella Clinical endocrinology 92 (2), 169-178, 2020 | 46 | 2020 |
| Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes D Giugliano, M Longo, L Scappaticcio, P Caruso, K Esposito Cardiovascular Diabetology 20, 1-10, 2021 | 44 | 2021 |
| Thyroid sequelae of COVID-19: a systematic review of reviews P Trimboli, C Camponovo, L Scappaticcio, G Bellastella, A Piccardo, ... Reviews in Endocrine and Metabolic Disorders 22 (2), 485-491, 2021 | 43 | 2021 |
| Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression MI Maiorino, M Longo, L Scappaticcio, G Bellastella, P Chiodini, ... Cardiovascular Diabetology 20, 1-10, 2021 | 40 | 2021 |
| Free and fixed‐ratio combinations of basal insulin and GLP‐1 receptor agonists versus basal insulin intensification in type 2 diabetes: a systematic review and meta‐analysis of … MI Maiorino, P Chiodini, G Bellastella, L Scappaticcio, M Longo, ... Diabetes, Obesity and Metabolism 20 (9), 2309-2313, 2018 | 40 | 2018 |
| Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a GLP-1RA or to basal insulin plus an SGLT2 inhibitor … D Giugliano, M Longo, P Caruso, R Di Fraia, L Scappaticcio, M Gicchino, ... Diabetes Care 44 (6), 1353-1360, 2021 | 37 | 2021 |
